CY1115394T1 - Φαρμακευτικη συνθεση του ιβuρrοfeν για ενεση - Google Patents
Φαρμακευτικη συνθεση του ιβuρrοfeν για ενεσηInfo
- Publication number
- CY1115394T1 CY1115394T1 CY20141100574T CY141100574T CY1115394T1 CY 1115394 T1 CY1115394 T1 CY 1115394T1 CY 20141100574 T CY20141100574 T CY 20141100574T CY 141100574 T CY141100574 T CY 141100574T CY 1115394 T1 CY1115394 T1 CY 1115394T1
- Authority
- CY
- Cyprus
- Prior art keywords
- injection
- containers
- ibuprofen
- iburrofen
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Φαρμακευτική σύνθεση του ibuprofen για ένεση που περιλαμβάνει ένα υδατικό διάλυμα ibuprofen και trometamol. Αυτές οι συνθέσεις εμφανίζουν ελάχιστη απώλεια δραστικού συστατικού και αποδεκτή αύξηση των ακαθαρσιών μετά από κλιβανισμό, ιδιότητες που έχουν αποδειχθεί μέσα σε διάφορους τύπους δοχείων, όπως δοχεία που κατασκευάζονται από πλαστικά όπως πολυπροπυλένιο, ΡVC και πολυαιθυλένιο καθώς και μέσα σε γυάλινα δοχεία. Αυτές οι συνθέσεις αφού υποβληθούν σε κλιβανισμό, εξακολουθούν να συμμορφώνονται με όλες τις σχετικές τεχνικές προδιαγραφές της Ευρωπαϊκής Φαρμακοποιίας (European Pharmacopoeia) και του USΡ.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/ES2010/070330 WO2011144766A1 (es) | 2010-05-18 | 2010-05-18 | Composición farmacéutica de ibuprofeno para inyección |
EP11720479.2A EP2571488B2 (en) | 2010-05-18 | 2011-05-18 | Pharmaceutical composition of ibuprofen for injection |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115394T1 true CY1115394T1 (el) | 2017-01-04 |
Family
ID=43589415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100574T CY1115394T1 (el) | 2010-05-18 | 2014-07-30 | Φαρμακευτικη συνθεση του ιβuρrοfeν για ενεση |
Country Status (35)
Country | Link |
---|---|
US (1) | US9114165B2 (el) |
EP (1) | EP2571488B2 (el) |
JP (1) | JP6018048B2 (el) |
KR (1) | KR101770808B1 (el) |
CN (1) | CN102892410B (el) |
AU (1) | AU2011254583B2 (el) |
BR (1) | BR112012029171B1 (el) |
CA (1) | CA2798575C (el) |
CL (1) | CL2012003119A1 (el) |
CO (1) | CO6650419A2 (el) |
CR (1) | CR20120559A (el) |
CY (1) | CY1115394T1 (el) |
DK (1) | DK2571488T4 (el) |
EC (1) | ECSP12012274A (el) |
ES (1) | ES2478491T5 (el) |
HK (1) | HK1177424A1 (el) |
HR (1) | HRP20140622T4 (el) |
IL (1) | IL222497A0 (el) |
MA (1) | MA34176B1 (el) |
ME (1) | ME01834B (el) |
MX (1) | MX2012013402A (el) |
MY (1) | MY160302A (el) |
NZ (1) | NZ602957A (el) |
PE (1) | PE20130374A1 (el) |
PL (1) | PL2571488T5 (el) |
PT (1) | PT2571488E (el) |
RS (1) | RS53408B2 (el) |
RU (1) | RU2012154628A (el) |
SG (1) | SG185061A1 (el) |
SI (1) | SI2571488T2 (el) |
SM (1) | SMT201400103B (el) |
TN (1) | TN2012000487A1 (el) |
UA (1) | UA103290C2 (el) |
WO (2) | WO2011144766A1 (el) |
ZA (1) | ZA201207948B (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9072710B2 (en) * | 2012-03-16 | 2015-07-07 | Cumberland Pharmaceuticals Inc. | Injectable ibuprofen formulation |
CN104323988A (zh) * | 2014-11-27 | 2015-02-04 | 北京蓝丹医药科技有限公司 | 一种用于注射的右旋布洛芬药物组合物 |
CN105055389B (zh) * | 2015-08-03 | 2018-08-10 | 北京蓝丹医药科技有限公司 | 一种用于早产儿先天性心脏病的布洛芬药物组合物 |
CN105997901A (zh) * | 2016-07-27 | 2016-10-12 | 济南东方开元医药新技术有限公司 | 小儿注射用布洛芬氨丁三醇冻干粉针组合物及制备方法 |
WO2020120756A1 (en) * | 2018-12-14 | 2020-06-18 | Fresenius Kabi Austria Gmbh | Pharmaceutical compositions for parenteral administration comprising ibuprofen and a phosphate buffer |
CN112526013B (zh) * | 2020-11-20 | 2022-09-06 | 人福普克药业(武汉)有限公司 | 超高液相色谱法检测布洛芬药物中有关物质浓度方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19912436A1 (de) | 1999-03-19 | 2000-09-21 | Merckle Gmbh | Ibuprofen-Lösung |
US20040132823A1 (en) | 2001-11-02 | 2004-07-08 | Leo Pavliv | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
CN1302771C (zh) | 2001-11-02 | 2007-03-07 | 坎伯兰医药品股份有限公司 | 2-(4-异丁苯基)丙酸的药物组合物 |
ITMI20040235A1 (it) | 2004-02-13 | 2004-05-13 | Therapicon Srl | Preparazione farmaceutica per il cavo orale |
-
2010
- 2010-05-18 WO PCT/ES2010/070330 patent/WO2011144766A1/es active Application Filing
-
2011
- 2011-05-18 RS RS20140366A patent/RS53408B2/sr unknown
- 2011-05-18 NZ NZ60295711A patent/NZ602957A/en unknown
- 2011-05-18 BR BR112012029171-8A patent/BR112012029171B1/pt active IP Right Grant
- 2011-05-18 JP JP2013510623A patent/JP6018048B2/ja active Active
- 2011-05-18 WO PCT/EP2011/058087 patent/WO2011144677A1/en active Application Filing
- 2011-05-18 PT PT11720479T patent/PT2571488E/pt unknown
- 2011-05-18 SI SI201130206T patent/SI2571488T2/sl unknown
- 2011-05-18 UA UAA201214485A patent/UA103290C2/ru unknown
- 2011-05-18 PL PL11720479T patent/PL2571488T5/pl unknown
- 2011-05-18 US US13/641,921 patent/US9114165B2/en active Active
- 2011-05-18 ME MEP-2014-74A patent/ME01834B/me unknown
- 2011-05-18 SG SG2012079570A patent/SG185061A1/en unknown
- 2011-05-18 MA MA35330A patent/MA34176B1/fr unknown
- 2011-05-18 ES ES11720479.2T patent/ES2478491T5/es active Active
- 2011-05-18 AU AU2011254583A patent/AU2011254583B2/en active Active
- 2011-05-18 PE PE2012002182A patent/PE20130374A1/es not_active Application Discontinuation
- 2011-05-18 KR KR1020127032850A patent/KR101770808B1/ko active IP Right Grant
- 2011-05-18 CA CA2798575A patent/CA2798575C/en active Active
- 2011-05-18 CN CN201180024380.7A patent/CN102892410B/zh not_active Ceased
- 2011-05-18 DK DK11720479.2T patent/DK2571488T4/en active
- 2011-05-18 RU RU2012154628/15A patent/RU2012154628A/ru unknown
- 2011-05-18 MY MYPI2012700890A patent/MY160302A/en unknown
- 2011-05-18 EP EP11720479.2A patent/EP2571488B2/en active Active
- 2011-05-18 MX MX2012013402A patent/MX2012013402A/es active IP Right Grant
-
2012
- 2012-10-09 TN TNP2012000487A patent/TN2012000487A1/en unknown
- 2012-10-17 IL IL222497A patent/IL222497A0/en unknown
- 2012-10-17 EC ECSP12012274 patent/ECSP12012274A/es unknown
- 2012-10-22 ZA ZA2012/07948A patent/ZA201207948B/en unknown
- 2012-11-01 CR CR20120559A patent/CR20120559A/es unknown
- 2012-11-07 CL CL2012003119A patent/CL2012003119A1/es unknown
- 2012-12-17 CO CO12228358A patent/CO6650419A2/es unknown
-
2013
- 2013-04-10 HK HK13104392.1A patent/HK1177424A1/xx not_active IP Right Cessation
-
2014
- 2014-06-30 HR HRP20140622TT patent/HRP20140622T4/hr unknown
- 2014-07-29 SM SM201400103T patent/SMT201400103B/xx unknown
- 2014-07-30 CY CY20141100574T patent/CY1115394T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1115394T1 (el) | Φαρμακευτικη συνθεση του ιβuρrοfeν για ενεση | |
CY1124690T1 (el) | Σκευασματα ενδοφλεβιου διαλυματος ποσακοναζολης σταθεροποιημενα με υποκατεστημενη βητα-κυκλοδεξτρινη | |
CY1122713T1 (el) | Στοματικα χορηγουμενες συνθεσεις κορτικοστεροειδων | |
EA201690107A1 (ru) | Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе | |
SI2648520T1 (en) | Formulation of dexmedetomidine pre-mixtures | |
CY1117479T1 (el) | Βενζοδιαζεπινικος αναστολεας bromodomain | |
CY1118099T1 (el) | Δισκια οξεικης ουλιπρισταλης | |
ECSP15004752A (es) | Formulaciones de etanercept que muestran una marcada reducción de la cantidad de partículas subvisibles | |
BR112015022861A8 (pt) | inibidores de bromodomínio | |
GT201600142A (es) | Composiciones farmacéuticas que comprenden azd9291 | |
BR112015018838A2 (pt) | estabilidade melhorada de novas composições líquidas | |
EA201390783A1 (ru) | Биоразлагаемые композиции для доставки лекарственных средств | |
EA201201519A1 (ru) | Способы комплексообразования с циклодекстринами для введения пептидных протеасомных ингибиторов в фармацевтические составы | |
EA201492172A1 (ru) | Биоразлагаемая композиция для доставки гидрофобных лекарственных средств | |
BR112012030818A2 (pt) | "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv" | |
BRPI0921705B8 (pt) | composição farmacêutica antimicrobiana e seu uso | |
EA201200604A1 (ru) | Фармацевтические субстанции на основе митохондриальноадресованных антиоксидантов | |
EA201890436A1 (ru) | Жидкая полимерная система доставки для длительного введения лекарственных средств | |
CR20110704A (es) | Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica | |
UY31880A (es) | Composiciones farmacéuticas mejoradas que contienen un medicamento antibiótico de fluoroquinolona | |
EA201690005A1 (ru) | Состав с модифицированной кинетикой высвобождения | |
IN2015DN02999A (el) | ||
EA201390950A1 (ru) | Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой | |
BR112015013223A2 (pt) | composição farmacêutica | |
CY1117873T1 (el) | ΣΤΕΡΕΕΣ ΜΟΡΦΕΣ (1r,4r)-6’-ΦΘΟΡΟ-(Ν,Ν-ΔΙΜΕΘΥΛΟ)-4-ΦΑΙΝΥΛΟ-4΄, 9΄-ΔΙΥΔΡΟ-3’Η-ΣΠΕΙΡΟ-[ΚΥΚΛΟΕΞΑΝΟ-1,1 '-ΠΥΡΑΝΟ-[3,4,b]ΙΝΔΟΛ]-4-ΑΜΙΝΗΣ ΚΑΙ ΘΕΙΙΚΟΥ ΟΞΕΟΣ |